Issued 2026-09-16 at $81.36 · now $81.36 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, SUNC has typically landed between $76.17 and $93.42 — a range of −6.4% to +14.8% from the issuance price $81.36.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
194 overlapping 1 month windows · 2025-11-06 – 2026-08-17 · basis climatology · forecast (batch).
The cone is anchored at the 2026-09-16 issuance close ($81.36) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where SUNC has typically landed a month from the 2026-09-16 close of $81.36 — the range is history, not a prediction.
- now $81.36 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $86.13 (+5.9%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $83.14–$89.13
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $76.17–$93.42
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2026-05-20 | −12.8% | −12.8% | +0.0% |
| 2026-05-19 | −12.8% | −13.4% | +0.0% |
| 2026-05-18 | −12.0% | −12.0% | +1.6% |
| 3 best | |||
| 2026-06-22 | +21.8% | +0.0% | +21.8% |
| 2026-06-24 | +20.5% | +0.0% | +20.5% |
| 2026-04-20 | +20.2% | +0.0% | +20.2% |
194 overlapping windows · 2025-11-06 – 2026-09-16 · not cherry-picked
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | Jennings Michael | director | Purchase | 1,000 @ $52.00 | $52K | +13.2% of holding | −7.4% | +19.1% | 8,590 | Form 4 · filed 5 days after the trade |
| 2025-11-17 | Jennings Michael | director | Purchase | 2,804 @ $49.68 | $139K | +61.1% of holding | −1.7% | +36.4% | 7,394 | Form 4 · filed 1 day after the trade |
| 2025-11-17 | Jennings Michael | director | Purchase | 165 @ $49.67 | $8K | +2.2% of holding | −1.7% | +36.4% | 7,559 | Form 4 · filed 1 day after the trade |
| 2025-11-17 | Jennings Michael | director | Purchase | 16 @ $49.64 | $794 | +0.2% of holding | −1.7% | +36.4% | 7,590 | Form 4 · filed 1 day after the trade |
| 2025-11-17 | Jennings Michael | director | Purchase | 15 @ $49.61 | $744 | +0.2% of holding | −1.7% | +36.4% | 7,574 | Form 4 · filed 1 day after the trade |
| 2025-11-10 | Kim Joseph | director | Purchase | 6,000 @ $48.97 | $294K | ownership Δ n/a | −0.0% | +37.0% | 6,000 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
4 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-03-06 | Jennings Michael | director | Award / grant | 2,436 | 13,526 | Form 4 |
| 2026-03-06 | Brannon Richard D | director | Award / grant | 2,436 | 4,936 | Form 4 |
| 2026-03-06 | Jennings Michael | director | Award / grant | 2,500 | 11,090 | Form 4 |
| 2026-03-06 | Brannon Richard D | director | Award / grant | 2,500 | 2,500 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.